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A plateau of breast cancer mortality in Poland – an impact
of time periods or birth generations?
A joinpoint regression and APC analysis of recent time trends
Jerzy E. Tyczyƒski
Breast cancer is the major cause of cancer deaths in women worldwide. In Poland, breast cancer has been the most frequent
cause of cancer deaths in females since 1976, when it overtook stomach cancer.
There were 1,587 deaths from breast cancer in Polish women in 1963. Over the next 3 decades the number of deaths caused
by that cancer increased to 4,738 in 1996. Crude mortality rate from breast cancer in Poland increased from 10.0/105 in 1963
to 23.9/105 in 1996. Overall age-standardised mortality rate from breast cancer increased within the same time period from
9.4/105 to 16.2/105.
In all ages combined, an increasing trend of mortality has been observed within the entire time period (1963-1996), however
a deceleration of mortality increase has been observed. Deceleration of the increase speed was observed in almost all age
categories.
Deceleration of mortality increase or first signs of decline were observed previously in several Western European countries,
United States, Canada, and Australia. It seems that the process of deceleration of mortality increase, which has begun in
Western countries in the 1970s and 1980s, has appeared in Poland about one decade later. It is, however, still difficult to
evaluate what are the main causes of that phenomenon, but it is most likely that several factors play a role simultaneously in
that process.
Ograniczenie wzrostu umieralnoÊci z powodu nowotworów z∏oÊliwych piersi w Polsce 
– wp∏yw okresu czasu czy generacji urodzeniowych? 
Analiza trendów czasowych przy u˝yciu metod: „joinpoint regression” oraz „age-period-cohort model”
Nowotwory z∏oÊliwe piersi sà najcz´strzà przyczynà zgonów na nowotwory wÊród kobiet na Êwiecie. W Polsce, rak piersi jest naj-
cz´strzà przyczynà zgonów na nowotwory z∏oÊliwe u kobiet od 1976 roku, kiedy zajà∏ miejsce nowotworów z∏oÊliwych ˝o∏àd-
ka jako najcz´Êciej notowanego nowotworu.
W 1963 roku zanotowano u kobiet w Polsce 1587 zgonów z powodu raka piersi. W ciàgu nast´pnych trzech dziesi´cioleci licz-
ba zgonów z powodu tego nowotworu wzros∏a do 4738 (w 1996 roku). „Surowy” wspó∏czynnik umieralnoÊci z powodu nowo-
tworów z∏oÊliwych piersi wzrós∏ w Polsce w latach 1963-1996 z 10.0/105 do 23.9/105. Standaryzowany wg wieku wspó∏czynnik
umieralnoÊci wzrós∏ w tym samym okresie z 9.4/105 to 16.2/105.
Jakkolwiek w ca∏ym analizowanym okresie (1963-1996) obserwowano wzrostowy trend umieralnoÊci na raka piersi ogó∏em
(we wszystkich grupach wieku ∏àcznie), to zanotowano równie˝ w tym czasie spadek tempa wzrostu. Zjawisko to odnotowa-
no w niemal wszystkich kategoriach wiekowych.
Spadek tempa wzrostu umieralnoÊci na raka piersi lub pierwsze symptomy spadku cz´stoÊci zgonów obserwowano wczeÊniej
w wielu krajach Europy Zachodniej, Kanadzie, USA i Australii. Wydaje si´, ˝e proces spowolnienia wzrostu umieralnoÊci, któ-
ry rozpoczà∏ sie w krajach zachodnich w latach 70. i 80. pojawi∏ si´ w Polsce oko∏o 10 lat póêniej. Jest jednak trudno oceniç
jednoznacznie jakie sà g∏ówne przyczyny tego zjawiska. Analiza dost´pnych danych wydaje si´ wskazywaç, ˝e wiele czynników
odgrywa równoczeÊnie rol´ w tym procesie.
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Introduction
Breast cancer is the major cause of cancer deaths in
women worldwide, and the most frequently registered
cancer in females. It has been estimated that in the year
2000 there were 373,000 breast cancer deaths worldwide
(6.0% of all cancer deaths), and approximately 1,050,000
new breast cancer cases (10.4% of all new cancer cases)
[1]. A prevalence of breast cancer in 2000 was estimated
for 3,860,000 cases [1].
In Europe, the highest rates are observed in Western
and Northern Europe, while the lowest rates dominate
in Eastern and Southern Europe [2].
In Poland, breast cancer has been the most frequent
cause of cancer deaths in females since 1976, when it
overtook stomach cancer (3). The percentage of breast
cancer deaths increased between 1963 and 1999 from 9%
to 13% [3].
Few systematic analysis of breast cancer mortality
in Poland have been published so far, covering the time
period until the second half of 1980s [4, 5]. This paper
aims to analyse time trends of breast cancer mortality in
Poland using two methods, not previously used for Polish
data: a joinpoint regression method and an age-period-
cohort modelling method [6-9].
Material and methods
Mortality from malignant neoplasms of the breast were extracted
from the World Health Organisation (WHO) Mortality
Databank, by five-year age group, using the rubric 174 according
to ICD-9 revision. Data were available for a 34 year period:
1963-1996. Corresponding population data, by age and calendar
year, were also extracted.
To evaluate changes in time trends, age-standardised rates
were calculated for all ages combined and for the following age
groups: 20-29, 30-39, 40-49, 50-64, 65-74, and 75 and over, using
the weights of the World Standard Population [10]. The joinpoint
regression was then employed to estimate annual percentage
change (EAPC) [6, 7]. For each EAPC estimate corresponding
95% confidence interval (95%CI) was also calculated
In order to fit „age-period-cohort” (APC) models, the data
were grouped into periods of five years and approximate
overlapping ten-year cohorts derived by subtracting the midpoint
of the five-year age group from the midpoint of the period. The
age range was restricted to persons dying of breast cancer at
age of 20 to 74.
The APC statistical model provides a quantitative and
comparable method of estimating trends over time, using a set of
objective criteria to choose the best description of the data.
Detailed description of the APC methodology has been
published elsewhere [8, 9, 11].
The following hierarchy of models was fitted to the breast
cancer mortality rates:
{1} Age;
{2} Age + (Period or Cohort) Drift;
{3a} Age + Drift + non-linear Period;
{3b} Age + Drift + non-linear Cohort;
{4} Age + Drift + non-linear Period + non-linear Cohort.
The relative contribution of each effect to the model was
determined by comparing the change in the deviance and
degrees of freedom in two sequentially fitted models with the
appropriate chi-squared statistic. Hence, a comparison of model
{2} with {1} provides a test for drift against the model of no
temporal trend (model {1}); a comparison of model {3a} versus
{2}, and model {3b} versus {2} tests for the effects of non-
linear period and non-linear cohort, respectively. Comparing
model {4} versus {3a} tests for the effects of non-linear cohort
effects, adjusting for drift and non-linear period. Finally, the
comparison of model {4} versus {3b} tests the effects of non-
linear period, adjusting for drift and non-linear cohort. 
Data on reproductive factors (i.e. number of children,
fertility, age at childbearing) were retrieved from the on-line
database of the Polish Central Statistical Office (GUS)
(www.stat.gov.pl) [12]. Data on survival of breast cancer patients
were derived from the EUROCARE-2 study [13].
Results
There were 1,587 deaths from breast cancer in Polish
women in 1963. Over the next 3 decades the number of
deaths caused by that cancer increased to 4,738 in 1996
(Table I). Crude mortality rate from breast cancer in
Poland increased from 10.0/105 in 1963 to 23.9/105 in
1996. Overall age-standardised mortality rate from breast
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Table I. Breast cancer mortality in Poland, 1963-1996
Females
Year Number of deaths Crude rate Age-standardised rate
1963 1 587 10.0 9.4
1964 1 779 11.1 10.1
1965 1 938 12.0 10.8
1966 1 969 12.1 10.8
1967 2 149 13.1 11.4
1968 2 128 12.8 11.0
1969 2 303 13.8 11.9
1970 2 270 13.6 11.5
1971 2 380 14.1 11.8
1972 2 527 14.9 12.3
1973 2 669 15.6 12.6
1974 2 790 16.1 12.9
1975 2 895 16.5 13.2
1976 3 065 17.4 13.8
1977 3 049 17.1 13.5
1978 3 225 18.0 14.1
1979 3 264 18.0 14.1
1980 3 446 18.9 14.8
1981 3 599 19.6 15.1
1982 3 641 19.6 15.0
1983 3 664 19.6 14.8
1984 3 792 20.1 15.2
1985 3 795 19.9 15.1
1986 3 844 20.0 15.1
1987 3 905 20.2 15.1
1988 4 045 20.9 15.5
1989 4 097 21.1 15.5
1990 4 323 22.1 16.1
1991 4 198 21.4 15.5
1992 4 429 22.5 16.2
1993 4 381 22.2 15.7
1994 4 449 22.5 15.9
1995 4 665 23.6 16.3
1996 4 738 23.9 16.2
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cancer increased within the same time period from 9.4/105
to 16.2/105 (Table I).
J o i n p o i n t  r e g r e s s i o n  a n a l y s i s
An analysis performed by joinpoint regression method
showed deceleration of EAPC for all ages combined as
well as in particular age categories (with an exception of
the oldest age group 75 years and more). Time trends
for all ages combined and for particular age categories
(observed and fitted) are presented in Figures 1 and 2.
In all ages combined, an increasing trend of mortality
has been observed within the entire time period (1963-
1996), however, a decreasing rate of mortality increase
has been observed. In the period 1965-1980 mortality
from breast cancer was increasing by 2.1% per year, while
in the period 1981-1996 the EAPC was 0.6% (Table II).
Similar changes were observed in middle-age and older
women (between 45 and 74 years of age). In the age
group 40-49 mortality was increasing by 2.0% per year
in 1963-1978, and 0.5% in 1979-1996. In the age group 50-
64 the EAPC was 2.5% in the years 1965-1979 and then
dropped to 0.2% in the period 1980-1996. In older women
aged 65-74 an EAPC of 2.2% was noted in 1965-1983
and 0.7% in 1984-1996 (Table II). There were no changes
of the EAPC in the oldest age group (75+) – mortality in
this age category was increasing at a rate of 2.1% per
year within the entire analysed time period.
Table II. Changes in breast cancer mortality time trends, females,
Poland 1963-1996 (joinpoint regression analysis)
Females
Age Number of Year of Period EAPC* 95%CI
joinpoints joinpoint
All 2 1963-1964 6.5 1.0 12.4
1965 1965-1980 2.1 1.9 2.3
1981 1981-1996 0.6 0.3 0.8
20-29 0 1963-1996 1.9 0.3 3.5
30-39 1 1963-1984 1.8 1.0 2.5
1985 1985-1996 -1.7 -3.6 0.4
40-49 1 1963-1978 2.0 1.5 2.5
1979 1979-1996 0.5 0.0 0.9
20-49 1 1963-1978 2.1 1.7 2.6
1979 1979-1996 0.3 -0.1 0.7
50-64 1 1963-1979 2.5 2.1 2.9
1980 1980-1996 0.2 -0.2 0.7
65-74 2 1963-1964 6.9 -3.6 18.5
1965 1965-1983 2.2 1.9 2.6
1984 1984-1996 0.7 0.0 1.3
75+ 0 1963-1996 2.1 1.9 2.3
50-75+ 2 1963-1964 8.5 0.9 16.7
1965 1965-1980 2.2 1.9 2.5
1981 1981-1996 0.7 0.4 1.0
* - Estimated Annual Percentage Change
The situation is somewhat different in young women
(30-39 years of age). After an increase of mortality in
1960s, 1970s and first half of 1980s by 1.8% per year,
there has been a decrease of mortality since 1985 (-1.7%
per year in the period 1985-1996) (Table II).
A g e - p e r i o d - c o h o r t  m o d e l l i n g
Five types of models were fitted for females, starting from
a simple “age” model to full “age+period+cohort”
model. Table III shows deviance and number of degrees
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Figure 1. Breast cancer morality, Poland, by age groups, females,
observed values (+) and jpinpoint regression (solid line)
Figure 2. Breast cancer morality, Poland, all ages pre- (20-49) and
postmenopausal (50+) females
of freedom with corresponding p-values for each
model fitted, as well as differences in deviance and
degrees of freedom (and their statistical significance)
between each two sequentially fitted models. It was found
that the model, which fits the data best and reaches
statistical significance, is full “age+period+cohort”
model.
Based on the best fitting model changes in risk of
breast cancer deaths were estimated. Table IV and
Figure 3 show changes in relative risk (RR) by subsequent
birth cohorts. The risk was increasing for all subsequent
birth cohorts until the cohort born between 1945-1949
(given marked as 1947 in the table and graph). A first
sign of a plateau was observed for the youngest birth
cohort, 1950-1955. Table V and Figure 4 present changes
in breast cancer risk by subsequent time period (taking
period 1967-1971 as reference category, RR=1). Analysis
showed that after an increase of risk in the first two 5-year
time periods (1972-1976 and 1977-1981) by about 12%,
a plateau of the RRs was observed within subsequent
periods.
Table V. Relative risk (RR) of breast cancer mortality, 
estimates for subsequent time periods
Females
Period RR 95%CI
1967-1971 1.00 (reference category)
1972-1976 1.06 1.03 1.10
1977-1981 1.12 1.07 1.17
1982-1986 1.12 1.05 1.19
1987-1991 1.11 1.02 1.20
1992-1996 1.10 1.00 1.21
Discussion
Breast cancers are derived from the epithelial cells that
line the terminal duct lobular unit. An invasive breast
cancer is one in which there is dissemination of cancer
cells outside the basement membrane of the ducts and
lobules into surrounding adjacent normal tissue [14].
Breast cancers were previously classified either as ductal
or lobular types, since it was believed that ductal
carcinomas arose from ducts and lobular carcinomas from
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Table III. Age-period-cohort (APC), breast cancer, females, Poland, 1967-1996
Model Deviance Number of df* p-value Difference of Difference in the p-value 
deviances number of df* (for difference 
between 
models)
AGE (A) 1028.5 45 0.000
AGE+DRIFT (AD) 205.0 44 0.000 823.5 1 0.000
AGE+COHORT (DRIFT)(AC) 76.4 32 0.000 128.6 12 0.000
AGE+PERIOD (DRIFT) (AP) 106.4 40 0.000 98.6 4 0.000
AGE+PEROD+COHORT (APC) 27.0 28 0.518
(a) Difference AP-APC 79.4 12 0.000
(b) Difference AC-APC 49.4 4 0,000
* - df - degrees of freedom
Figure 4. Relative risk by period of time, breast, females, Poland
Figure 3. Relative risk for subsequent birth cohorts, breast, females,
Poland
Table IV. Relative risk (RR) of breast cancer mortality, 
estimates for subsequent birth cohorts
Females
Cohort RR 95%CI
1897 0.70 0.62 0.79
1902 0.77 0.71 0.84
1907 0.81 0.76 0.87
1912 0.89 0.85 0.94
1917 0.95 0.92 0.99
1922 1.00 reference category
1927 1.02 0.99 1.05
1932 1.05 1.01 1.10
1937 1.08 1.01 1.15
1942 1.13 1.04 1.22
1947 1.21 1.10 1.33
1952 1.20 1.07 1.35
lobules. It is known now that both invasive ductal and
lobular breast cancers arise from the terminal duct lobular
unit [14].
This paper aims to present changes in the mortality
from breast cancer in Poland over the last three decades,
and to analyse these changes in the light of the major
breast cancer risk factors. The current analysis is based
on the data until 1996 and employs two methodological
approaches to evaluate changes in time trends and
influence of period of time and birth cohort on the
mortality rates. It was not possible to evaluate changes
in mortality after 1996 since the quality of mortality
data from Poland for the years 1997-1998 was insufficient
[3].
During the last three decades breast cancer has
become the most frequent cause of cancer deaths in
Polish women. Between 1963 and 1996 the absolute
number of deaths and age-standardised mortality rates
increased by 198% and 72% respectively.
An increase in breast cancer mortality in Poland was
previously reported by Staszewski [15]. Time trends of
mortality from breast cancer in Poland were later
discussed by Zatoƒski and Becker [4] and Zatoƒski [5],
and breast cancer epidemiology in Poland was also
described by Wronkowski et al. [16, 17]. It was pointed out
by Zatoƒski [5] that after 1980 some deceleration of
increase of mortality has taken place. Our analysis
confirmed this observation and quantified the magnitude
of that phenomenon (Table II, V). Moreover, if the
estimation is done based upon the APC modelling, taking
into account both linear and non-linear effect of period of
time and birth cohort, no increase of risk has been
observed for subsequent periods of time since 1977-1981.
It was also previously pointed out that deceleration of
mortality increase in time was accompanied by permanent
increase of risk for subsequent birth generations [5]. Our
analysis shows that risk was increasing until the birth
cohort 1945-1949. For the youngest birth generation
(1950-1954) a first sign of levelling off has been observed.
Deceleration of the all-ages increase of mortality has
been accompanied by first signs of decrease in young
women (age 30-39), starting in mid 1980s. In general, in
all age categories (with an exception of the youngest
(aged 20-29) and elderly women aged 75 years or more)
favourable changes have been observed: either slowing
down of mortality increase (all ages combined and age
groups between 40 and 74) or even decrease of mortality
(age group 30-39).
Deceleration of mortality increase or first symptoms
of decline were observed previously in several Western
European countries, United States, Canada, and Australia
[18]. It seems that the process of deceleration of mortality
increase, which has begun in Western countries in the
1970s and 1980s, has appeared in Poland about one
decade later.
Although the APC modelling shows statistical
significance of both period and cohort in the full
“age+period+cohort” model, an analysis of the relative
contribution of them to the model indicates greater
impact of period effect on mortality. However, some
impact of cohort effect on the youngest age groups has
also been observed.
There are several factors, both endo- and exogenous,
which are known to affect risk of breast cancer in the
population. These are factors such as: lifestyle (i.e.
childbearing, breastfeeding, type of diet, obesity, use of
alcohol and tobacco), hormonal status (influencing age at
menarche and menstrual cycle, and determined by
endogenous hormones, oral contraceptives use, and
hormonal replacement therapy), anthropometric cha-
racteristic, radiation, and genetic predisposition [19, 20].
Finally, mortality from breast cancer may be influenced by
prevention (e.g. chemoprevention using tamoxifen or
raloxifene) and screening [21, 22].
Although several of those factors may be responsible
for changes in breast cancer mortality in Poland, relatively
little is known about their occurrence in the Polish
population.
Population-based early detection has not been
the reason for breast cancer mortality levelling off in
Polish women observed since early 1980s, since such
a programme did not exist in Poland in the 1970s and
1980s. Another possible responsible factor may be
advances in treatment procedures, and the introduction of
tamoxifen adjuvant therapy may well be among them.
The effectiveness of tamoxifen in reducing mortality from
breast cancer has been shown in several randomised
clinical trials [23, 24]. The best effects were observed in
ER-positive breast cancer patients [24]. High effectiveness
of tamoxifen in preventing invasive breast cancers among
women diagnosed with DCIS (ductal carcinoma in situ)
has also been shown [25]. It has been estimated by Cuzick
[26] that an overall reduction of breast cancer incidence as
a result of tamoxifen administration may reach 40%.
Although it is likely, that introduction of tamoxifen
prevention and adjuvant therapy will affect future trends
of breast cancer in Poland, no association can be
established with past mortality trends of this disease.
There have been several studies showing relationship
between several reproductive factors and risk of breast
cancer incidence and mortality. It has been shown that
risk of breast cancer is increasing with decreasing age at
menarche, increasing age at first pregnancy, increasing
age at menopause, and low parity [27, 28]. The data from
Poland show that the average number of children born by
Polish women aged 20-24 and 25-29 increased between
1970 and 1983 by approximately 15% in both age groups
(Figure 5). However, after 1983 the average number of
children born has been decreasing in all age categories,
especially among women aged 20-24 (decrease by 57%
between 1983 and 2000) (Figure 5) [12]. It should also be
pointed out that in the 1970s and 1980s the average age of
women at first birth increased, and, after a temporary
decrease in the first half of 1990s, has continued to
increase in the 2nd half of the 1990s (Figure 6). The
fertility rate in Polish women was relatively stable in the
1970s, and has been consistently decreasing since the
early the 1980s (Figure 6). Significant changes have taken
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place also with regard to age at menarche in Polish girls
after the Second World War. After a significant decrease
of age at menarche observed until late 1970s, reverse
trend has been noted in the 1980s and early 1990s [29, 30].
It does not seem that changes in reproductive factors
alone might have a significant favourable impact on
levelling off of the breast cancer mortality in Poland.
There are several life-style risk factors known or
suspected to influence risk of breast cancer. Although
several studies in the past suggested some association
(both positive and negative) between exposure to tobacco
smoke and breast cancer risk, no convincing evidences
were found that both active and passive (second hand)
tobacco smoking plays an important role in the risk of
breast cancer [31-33]. However, epidemiological data
concerning tobacco smoking and breast cancer are
inconsistent [34, 35]. Since the relationship between
smoking and breast cancer seems to be rather weak, it is
unlikely that changes in tobacco smoking in Polish women
has affected breast cancer mortality in the past.
Mortality from cancer is a function of two main
factors: incidence rates and survival. Although incidence
data for the whole of Poland in the past suffered from
underreporting [3], data from some selected regional
cancer registries suggest increasing trends in breast cancer
incidence in the 1970s and 1980s [36]. On the other hand,
EURACARE-2 data show that between the late 1970s
and late 1980s a significant increase in breast cancer
survival took place in Poland (Figure 7) [13]. The plateau
in mortality from breast cancer observed in the 1980s
and 1990s may be an outcome of increasing incidence
and improving survival in Polish women.
Experiences from other countries (United Kingdom,
Sweden, the Netherlands) show that one of the pathways
to reduce mortality from breast cancer is mammography
screening of healthy women in a given range of age. There
is sufficient evidence that mammography screening can be
efficient in women between 50 and 69 years of age [22].
However, there in not sufficient evidence that this type of
screening may decrease mortality in women below 50 and
over 69, and is not effective in women in high-risk groups
(e.g. carriers of BRCA1 and BRCA2 mutations). It has
been suggested by some authors that screening should
be performed in women aged 40-50 every 2 years and
each year in women over 50 [37], as well as in high-risk
groups from age 35 every 12 months [38]. It seems that
recent results from clinical trials and population-based
screening programmes do not support such recom-
mendations [22].
The phenomenon of a slowing down of increase of
breast cancer mortality in Poland is difficult to be
unequivocally explained in view of changes of known risk
factors. It is most likely that several factors may play
a role simultaneously. There is, however, a need for
further studies to show which factors play a major role in
that process.
Jerzy E. Tyczyƒski PhD
Unit of Descriptive Epidemiology
International Agency for Research on Cancer
150 cours Albert-Thomas
69372 Lyon Cedex 08, France
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Figure 5. Number of live-born children by mothers’ age groups, per
1000 women, Poland, 1960-2000
Figure 6. Fertility rate and average age at first birth in Polish women,
1970-2000
Figure 7. 5-year relative survivals in Poland and in Europe, breast
cancer, females
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